Although it has been reported that GSG2 is highly expressed in ovarian cancer (Huang et al. 2021), the mechanism of GSG2 promoting the development and progress of ovarian cancer has not been clarified. The gene discussed is HASPIN; the disease is ovarian carcinoma.